Danone Valuation
Is BSN undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of BSN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: BSN (€61.48) is trading below our estimate of fair value (€93.31)
Significantly Below Fair Value: BSN is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for BSN?
Key metric: As BSN is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is BSN's PE Ratio? | |
|---|---|
| PE Ratio | 42x |
| Earnings | €1.00b |
| Market Cap | €42.13b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.9x |
| Enterprise Value/EBITDA | 10.9x |
| PEG Ratio | 2.3x |
Price to Earnings Ratio vs Peers
How does BSN's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 20.4x | ||
SO Smart Organic AD | 18.5x | n/a | лв231.4m |
HSY Hershey | 19.8x | 2.7% | US$35.5b |
GIS General Mills | 15.2x | 3.6% | US$36.4b |
KHC Kraft Heinz | 28.2x | 28.4% | US$38.7b |
BSN Danone | 42x | 18.4% | €42.1b |
Price-To-Earnings vs Peers: BSN is expensive based on its Price-To-Earnings Ratio (42x) compared to the peer average (20.4x).
Price to Earnings Ratio vs Industry
How does BSN's PE Ratio compare vs other companies in the European Food Industry?
| 3 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 3 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: BSN is expensive based on its Price-To-Earnings Ratio (42x) compared to the European Food industry average (13.4x).
Price to Earnings Ratio vs Fair Ratio
What is BSN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 42x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate BSN's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
AGRANA Beteiligungs-Aktiengesellschaft
€684.3m
Operates as an industrial processor of agricultural raw materials in Austria, Hungary, Romania, rest of Europe, and internationally.
AGB2
€11.10
7D
0%
1Y
-18.8%
Kraft Heinz
US$38.7b
Manufactures and markets food and beverage products in North America and internationally.
KHNZ
US$32.87
7D
0%
1Y
n/a
British American Tobacco
UK£66.0b
Engages in the provision of tobacco and nicotine products to consumers worldwide.
BMT
UK£35.04
7D
1.9%
1Y
n/a